• Je něco špatně v tomto záznamu ?

In silico library screening to find novel anticancer agent with chemosensitizing properties: Focus on targeting ataxia telangiectasia and Rad3 related kinase

Darina Muthna, Tomas Kucera, Zbynek Vecera, Lukas Gorecki, Martin Andrs, Martina Rezacova, Jan Korabecny

. 2024 ; 93 (1) : 68-83. [pub] 20240301

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc24004159

To bypass the resistance to conventional chemotherapy, attention is paid to the inhibition of alternative targets such as members of the DNA damage response pathway. In the present study, we performed a three-step virtual screening of potential ATR inhibitors followed by evaluation of antiproliferative and chemosensitizing properties of selected compounds in vitro on a panel of cancer cell lines. According to pharmacophore resemblance to standard ATR inhibitor VX-970, a total of 17 compounds were purchased and tested. Among those 17 compounds, two proved antiproliferative efficacy in monotherapy, whereas ten compounds were effective in cisplatin co-treatment on the panel of ten different human cell lines.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24004159
003      
CZ-PrNML
005      
20240424140304.0
007      
ta
008      
240328s2024 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.31482/mmsl.2023.009 $2 doi
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Záškodová, Darina $7 xx0305436 $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove
245    10
$a In silico library screening to find novel anticancer agent with chemosensitizing properties: Focus on targeting ataxia telangiectasia and Rad3 related kinase / $c Darina Muthna, Tomas Kucera, Zbynek Vecera, Lukas Gorecki, Martin Andrs, Martina Rezacova, Jan Korabecny
520    9_
$a To bypass the resistance to conventional chemotherapy, attention is paid to the inhibition of alternative targets such as members of the DNA damage response pathway. In the present study, we performed a three-step virtual screening of potential ATR inhibitors followed by evaluation of antiproliferative and chemosensitizing properties of selected compounds in vitro on a panel of cancer cell lines. According to pharmacophore resemblance to standard ATR inhibitor VX-970, a total of 17 compounds were purchased and tested. Among those 17 compounds, two proved antiproliferative efficacy in monotherapy, whereas ten compounds were effective in cisplatin co-treatment on the panel of ten different human cell lines.
650    _7
$a lidé $7 D006801 $2 czmesh
650    17
$a nádory $x farmakoterapie $7 D009369 $2 czmesh
650    _7
$a vyvíjení léků $7 D000076722 $2 czmesh
650    _7
$a protein-serin-threoninkinasy $x antagonisté a inhibitory $x farmakologie $x terapeutické užití $7 D017346 $2 czmesh
700    1_
$a Kučera, Tomáš, $d 1991- $7 xx0240426 $u Department of Toxicology and Military Pharmacy, Hradec Kralove
700    1_
$a Večeřa, Zbyněk $u Department of Toxicology and Military Pharmacy, Hradec Kralove $7 mub20221155934
700    1_
$a Górecki, Lukáš $u Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove $7 xx0243228
700    1_
$a Andrš, Martin $u Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove $7 xx0315711
700    1_
$a Řezáčová, Martina, $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove $d 1972- $7 nlk20020124956
700    1_
$a Korábečný, Jan $u Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove $7 xx0119837
773    0_
$t Vojenské zdravotnické listy $x 0372-7025 $g Roč. 93, č. 1 (2024), s. 68-83 $w MED00011116
856    41
$u https://mmsl.cz/artkey/mms-202401-0008_in-silico-library-screening-to-find-novel-anticancer-agent-with-chemosensitizing-properties-focus-on-targeting.php $y plný text volně přístupný
910    __
$a ABA008 $b A 3 $c 1073 $y p $z 0
990    __
$a 20240307 $b ABA008
991    __
$a 20240424140611 $b ABA008
999    __
$a ok $b bmc $g 2072317 $s 1213912
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2024 $b 93 $c 1 $d 68-83 $e 20240301 $i 0372-7025 $m Vojenské zdravotnické listy $x MED00011116
LZP    __
$c NLK109 $d 20240424 $b NLK111 $a Actavia-MED00011116-20240307

Najít záznam

Citační ukazatele

Možnosti archivace